INVO Bioscience, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
INVO Bioscience, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • INVO Bioscience, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$342K, a 99.4% decline year-over-year.
  • INVO Bioscience, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$1.81M, a 273% decline year-over-year.
  • INVO Bioscience, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.24M, a 371% decline from 2022.
  • INVO Bioscience, Inc. annual Nonoperating Income (Expense) for 2022 was -$263K, a 81.6% increase from 2021.
  • INVO Bioscience, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.43M, a 49.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.24M -$977K -371% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-04-17
2022 -$263K +$1.17M +81.6% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-04-17
2021 -$1.43M +$1.4M +49.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$2.83M -$2.45M -647% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$379K +$63K +14.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$442K -$380K -616% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$61.7K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.